Sage Therapeutics (SAGE) Financials

Sage Therapeutics Inc (SAGE) is a biopharmaceutical company that focuses on the development and commercialization of novel medicines to treat central nervous system disorders. The company's income statement provides a snapshot of its financial performance over a specific period. It shows the company's revenue, expenses, and net income. SAGE's total revenue includes the sales of its products and other sources of income. The gross profit represents the difference between the company's revenue and the cost of goods sold. SAGE's net income from stockholders is calculated by subtracting all expenses, including taxes and interest, from the gross profit.

SAGE's balance sheet provides a snapshot of the company's financial position at a specific point in time. It lists the company's assets, liabilities, and stockholders' equity. The total assets include cash equivalents, investments, property, and equipment. The total liabilities represent the company's debts and obligations. SAGE's stockholders' equity represents the ownership interest in the company. This includes the initial investment and retained earnings. The net debt is calculated by subtracting the company's cash equivalents from its total debt. It reflects the company's ability to meet its financial obligations.

SAGE's cash flow statement provides information about the company's cash inflows and outflows during a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. The operating cash flow measures the cash generated from the company's normal business operations. This includes cash received from customers and cash paid to suppliers and employees. The investing cash flow represents the cash used for investments, such as the acquisition of property and equipment or the purchase of other companies. The financing cash flow includes cash inflows and outflows related to the company's financing activities, such as issuing or repurchasing stock and borrowing or repaying debt. The free cash flow is calculated by subtracting the company's capital expenditures from its operating cash flow. It represents the cash available for discretionary purposes, such as dividend payments or acquisitions.

In summary, Sage Therapeutics Inc (SAGE) provides a comprehensive set of financial statements that give insights into the company's financial performance, position, and cash flow. These statements are essential for investors, analysts, and other stakeholders to evaluate the company's financial health and make informed decisions.